The evening of my cancer diagnosis, I started mentally referring to it as "the beast." In my case, the scientific name of the beast I was to be battle is triple negative breast cancer. Triple negative indicates that the breast cancer is not fueled by estrogen receptors, progesterone receptors or human epidermal growth factor receptor 2 (HER2). The good news is that this subtype of breast cancer is very responsive to chemotherapy, sometimes to the point where the tumor can shrink to nothing. I won't have to take hormone replacement pills after treatment, unlike women with other types of breast cancer, because my cancer is not hormone driven. However, the cancer that's chosen to invade my breast can be particularly aggressive, which is why it grew from nothing in August, to 2.3 cm in October, to 3.5 cm by the time chemo started in November. This type of cancer is more likely to recur than other subtypes of breast cancer. I felt violated by these cells, wanting this beast out as soon as possible.